DESIGN OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2/3 STUDY WITH AN OPEN-LABEL EXTENSION TO EVALUATE EFGARTIGIMOD IV IN PEDIATRIC PARTICIPANTS WITH IMMUNE THROMBOCYTOPENIA (ADVANCE JR)
EHA Library, John Grainger,
4210853
REAL‑WORLD EFFECTIVENESS OF IMMUNOGLOBULIN-REPLACEMENT THERAPY IN MITIGATING INFECTION RISK AMONG PATIENTS WITH NON-HODGKIN LYMPHOMA, MULTIPLE MYELOMA, AND CHRONIC LYMPHOCYTIC LEUKEMIA
EHA Library, Antoine Azar,
4210808